Efficacy and long term safety of fenfluramine in patients with Dravet syndrome

Trial Profile

Efficacy and long term safety of fenfluramine in patients with Dravet syndrome

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 23 Nov 2016

At a glance

  • Drugs Fenfluramine (Primary) ; Valproate
  • Indications Dravet syndrome
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 Nov 2016 According to a Zogenix media release, new data will be presented at 70th Annual American Epilepsy Society Meeting.
    • 07 Nov 2016 Effectiveness and safety resutls from this trial published in the European Journal of Neurology, according to a Zogenix Inc. media release.
    • 20 May 2016 A 5-Year Follow Up (2010-2014) Results (n=10) published in the Epilepsia
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top